| William Shrewsberry, CRNA | |
|
454 Mcdowell St, Welch, WV 24801-2029 | |
| (304) 436-8461 | |
| Not Available |
| Full Name | William Shrewsberry |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Location | 454 Mcdowell St, Welch, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235155201 | NPI | - | NPPES |
| 0065384000 | Medicaid | WV | |
| 1235155201 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 39835 (West Virginia) | Secondary |
| 363L00000X | Nurse Practitioner | 35607 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William Shrewsberry, CRNA Po Box 634712, Cincinnati, OH 45263-0001 Ph: () - | William Shrewsberry, CRNA 454 Mcdowell St, Welch, WV 24801-2029 Ph: (304) 436-8461 |
News Archive
The official Republican response to President Barack Obama's speech, delivered by Rep. Charles Boustany, R-La., was overshadowed by Rep. Joe Wilson's "You lie," remark Newsweek reports.
The drug telaprevir has been available for treatment of chronic hepatitis C infection of genotype 1 since autumn 2011. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether telaprevir offers an added benefit compared with the present standard therapy.
Fluxion Biosciences, a leading developer of microfluidic systems for functional cell analysis, today announced that it has received a $1.8 million NIH grant for the development of a high-throughput screening platform for anti-microbial drug discovery.
Promedior, Inc., a clinical stage biotechnology company developing novel therapeutics for the treatment of fibrosis, today announced that principal investigator, Srdan Verstovsek, MD, PhD, will present interim data from the Company's ongoing Phase 2 clinical trial of its lead product candidate, PRM-151, for the treatment of myelofibrosis, in a poster presentation on June 2, 2014 at the American Society for Clinical Oncology 2014 Annual Meeting.
› Verified 8 days ago
Julia Blevins, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 454 Mcdowell St, Welch, WV 24801 Phone: 304-436-8630 | |
Carol Suzanne Dennison, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 950 Mount View Rd, Welch, WV 24801 Phone: 304-436-4798 | |
Anthony Dillon, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 959 Mount View High School Rd, Welch, WV 24801 Phone: 304-436-4798 | |
Tara Morgan, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 795 Virginia Ave, Welch, WV 24801 Phone: 304-436-5420 Fax: 304-436-5036 | |
Dorothy Marie Green, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 454 Mcdowell St, Welch, WV 24801 Phone: 304-436-8461 | |
Jennifer Fain, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 19771 Coal Heritage Rd, Welch, WV 24801 Phone: 304-436-6650 Fax: 304-436-2629 | |
Mrs. Ashley Nicole Lovern, MSN, APRN, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 19771 Coal Heritage Rd, Welch, WV 24801 Phone: 304-436-6650 |